Luca Cindolo1, Philippe E Spiess2, Maida Bada3, Juan J Chipollini2, Peter Nyirády4, Paolo Chiodini5, Judith Varga4, Pasquale Ditonno6, Michele Battaglia6, Cosimo De Nunzio7, Giorgia Tema7, Alessandro Veccia8, Alessandro Antonelli8, Gennaro Musi9, Ottavio De Cobelli9, Andrea Conti9, Salvatore Micali10, Mario Álvarez-Maestro11, José Quesada Olarte11, Erico Diogenes12, Marcos Venicio Alves Lima12, Andrew Tracey13, Georgi Guruli13, Riccardo Autorino13, Petros Sountoulides14, Luigi Schips15. 1. Department of Urology, ASL 2 Abruzzo, Hospital "S. Pio da Pietrelcina", Vasto, Italy. lucacindolo@virgilio.it. 2. Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA. 3. Department of Urology, ASL 2 Abruzzo, Hospital "S. Pio da Pietrelcina", Vasto, Italy. 4. Department of Urology, Hospital of Budapest, Budapest, Hungary. 5. Medical Statistics Unit, University of Campania "Luigi Vanvitelli", Naples, Italy. 6. Department of Emergency and Organ Transplantation, Urology and Andrology Unit II, University of Bari, Bari, Italy. 7. Department of Urology, Hospital "Sant' Andrea", Sapienza University, Rome, Italy. 8. Department of Urology, Hospital "Spedali Civili", Brescia, Italy. 9. Department of Urology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. 10. Department of Urology, University of Modena and Reggio Emilia, Modena, Italy. 11. Department of Urology, Hospital Universitario La Paz, Madrid, Spain. 12. Department of Urology, Ceara Cancer Institute, Fortaleza, Brazil. 13. Department of Urology, Virginia Commonwealth University, Richmond, VA, USA. 14. Department of Urology, General Hospital of Veria, Veria, Greece. 15. Department of Urology, "G.D'Annunzio" University, Chieti, Italy.
Abstract
INTRODUCTION: We aimed to evaluate adherence to the EAU guidelines (GL) on penile cancer (PC) with regard to primary surgical treatment and management of lymph nodes and to estimate the influence of adherence to GL on clinical outcome. MATERIALS AND METHODS: This is a retrospective multicenter study (PEnile Cancer ADherence study, PECAD Study) on PC patients treated at 12 European and American centers between 2010 and 2016. Adherence to the EAU GL on the surgical management of the primary penile tumor and lymphadenectomy was evaluated. Descriptive analyses were performed, and survival curves were estimated. RESULTS: Data on 425 patients were considered for the analysis. The EAU GL on surgical treatment of the primary tumor and lymphadenectomy were respected in 74.8% and 73.7% of cases, respectively. Survival analysis showed that adherence to the GL on primary penile surgery was significantly associated with a good overall survival [adjusted HR 0.40 (95% CI 0.20-0.83, p value = 0.014)]. Also, the adherence to the GL on lymphadenectomy was statistically significantly associated with overall survival [adjusted HR 0.48 (95% CI 0.24-0.96, p value = 0.038)]. Limited follow-up and retrospective design represent limitations of this study. CONCLUSIONS: Our findings suggest that there is a good adherence to the EAU GL on PC. However, this should be further reinforced, endorsed and encouraged as it might translate into better clinical outcomes for PC patients.
INTRODUCTION: We aimed to evaluate adherence to the EAU guidelines (GL) on penile cancer (PC) with regard to primary surgical treatment and management of lymph nodes and to estimate the influence of adherence to GL on clinical outcome. MATERIALS AND METHODS: This is a retrospective multicenter study (PEnile Cancer ADherence study, PECAD Study) on PC patients treated at 12 European and American centers between 2010 and 2016. Adherence to the EAU GL on the surgical management of the primary penile tumor and lymphadenectomy was evaluated. Descriptive analyses were performed, and survival curves were estimated. RESULTS: Data on 425 patients were considered for the analysis. The EAU GL on surgical treatment of the primary tumor and lymphadenectomy were respected in 74.8% and 73.7% of cases, respectively. Survival analysis showed that adherence to the GL on primary penile surgery was significantly associated with a good overall survival [adjusted HR 0.40 (95% CI 0.20-0.83, p value = 0.014)]. Also, the adherence to the GL on lymphadenectomy was statistically significantly associated with overall survival [adjusted HR 0.48 (95% CI 0.24-0.96, p value = 0.038)]. Limited follow-up and retrospective design represent limitations of this study. CONCLUSIONS: Our findings suggest that there is a good adherence to the EAU GL on PC. However, this should be further reinforced, endorsed and encouraged as it might translate into better clinical outcomes for PC patients.
Authors: Marianne J Heins; Judith D de Jong; Inge Spronk; Vincent K Y Ho; Mirian Brink; Joke C Korevaar Journal: Eur J Public Health Date: 2017-08-01 Impact factor: 3.367
Authors: F A Distler; S Pahernik; G Gakis; G Hutterer; S Lebentrau; M Rink; P Nuhn; S Brookman-May; M Burger; C Gratzke; I Wolff; M May Journal: World J Urol Date: 2019-12-13 Impact factor: 4.226
Authors: Maximilian Pallauf; Marie C Hempel; Marie C Hupe; Matthias May; Marlene Haccius; Dorothea Weckermann; Steffen Lebentrau; Bernd Hoschke; Ulrike Necknig; Jesco Pfitzenmaier; Lukas Manka; Philipp Nuhn; Peter Törzsök; Lukas Lusuardi; Axel S Merseburger Journal: Adv Ther Date: 2020-10-10 Impact factor: 3.845
Authors: Andrej Panic; Henning Reis; Alina Wittka; Christopher Darr; Boris Hadaschik; Verena Jendrossek; Diana Klein Journal: Front Oncol Date: 2021-03-31 Impact factor: 6.244
Authors: Steffen Lebentrau; Gamal Anton Wakileh; Martin Schostak; Hans-Peter Schmid; Rodrigo Suarez-Ibarrola; Axel S Merseburger; Georg C Hutterer; Ulrike H Necknig; Michael Rink; Martin Bögemann; Luis Alex Kluth; Armin Pycha; Maximilian Burger; Sabine D Brookman-May; Johannes Bründl; Matthias May Journal: Front Oncol Date: 2021-11-29 Impact factor: 6.244